Developing a healthy future

Sypharma is an Australian speciality contract manufacturing group, motivated by a commitment to creating healthier futures.

Since 2005 we’ve developed and manufactured therapeutic goods, veterinary products, and speciality consumer products.

We’re a trusted partner and provider of biotechnology healthcare products in Australia and we partner to contract manufacture products for local and international markets.

Our Capabilities

At Sypharma we specialise in contract manufacturing products for early clinical to Phase I, II, and III clinical trials, and have a range of multipurpose cleanrooms for the manufacture of oral or topical drugs and devices.

Equipped with modern, comprehensive and specialised manufacturing equipment services, our expertise and experience are available to clients seeking the manufacture and packaging of therapeutic goods, veterinary products and consumer items. Our licenses include accreditation from the FDA, TGA, ISO13485 and USFDA.

Our Products

Sypharma manufactures products from R&D right through to commercial volumes, both large and small volume parenteral and has a veterinary manufacturing suite which is distributed under the brands Sykes, Rudduck, Potties, Vetex, and Rapidvite.

Innovation at Sypharma

In addition to contract manufacturing development, we work with partners to innovate and develop new technologies.

Sypharma has a proven track record of successful drug development within the national and international arena and the expertise to manage end-to-end development within a world-class Australian facility.

Latest News

Sypharma and Schott Unlocking Possibilities Together

April 6, 2023

SYPHARMA is a contract manufacturer based in Victoria, Australia that specializes in the production of both sterile and non-sterile biopharmaceutical…

Read More

Technovalia, Sypharma and BioNet announce the establishment of Genetis

March 21, 2022

Technovalia, Sypharma and BioNet announce the establishment of Genetis, the first Australian Vaccine Development and Manufacturing Hub for mRNA, DNA…

Read More

COVAX-19 vaccine reaches major milestone in the race for approval

August 27, 2021

COVID-19 vaccine developed by Vaxine Pty Ltd is the first Australian vaccine to reach final Phase 2 and 3 clinical…

Read More